TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Concentration of cortisol in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: length of stay (LOS) until discharge criteria met
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum pain rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: highest nausea rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drop in the absolute risk of death
Endpoint domain: Mortality/survival
Primary endpoint: cost-effectiveness per YLG
Endpoint domain: Resource use
Primary endpoint: Mean ventricular rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of AV block
Endpoint domain: Adverse events/effects
Primary endpoint: total plantarflexor muscle volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: maximum isometric plantarflexion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 6‐min walk test distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted serum phosphorus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: UAGT-to-creatinine ratio (UAGT/Cr, μg/g)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic Blood Pressure (SBP, mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MG plugging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MG secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eyelid redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total dose of dobutamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of medical visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: KPS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Unscheduled healthcare use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in daily NSAID requirement by >30%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return of organized rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Arousal Index (AI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hypopnea Index (HI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean Oxygen Saturation (mSaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum S‐100 protein concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Index of neurologic deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of postanesthetic hypothermia and shivering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient global impression of change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Return to work process
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Endoscopist mean satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hemodynamic instability
Endpoint domain: Adverse events/effects
Primary endpoint: hemodynamic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost of infusion treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: facilitated falling asleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: decreased nocturnal restlessness and awakenings
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: cognitive aging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: therapy discontinuation due to toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: treatment refusal
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in obstruction attenuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological impact of MS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average SpO2 during sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative middle ear pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total remission of OSA (Obstructive Sleep Apnea)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worst breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Acute Panic Inventory scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Control of symptoms of Tourette's disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute and relative PPO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean onset and duration of action
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in lidocaine dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in women's sexual dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean diameter of the wheal induced by prick tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean specific IgE values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of sensitized subjects allergic to mustard
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody production to TNFbp dimer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-life of TNFbp dimer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance of TNFbp dimer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma-free insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Eligibility for surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ESS skills performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AF recurrence rate at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Incomplete stent apposition prevalence
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in Kupperman Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the number of hot flushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pointing accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed speech development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Delayed motor development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: overall five-year survival (OS5)
Endpoint domain: Mortality/survival
Primary endpoint: NOSE scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Amount of plasma transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Median K(trans)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic BP (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative nausea and vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of nonurgent PED utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of sick visits to PCP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: oxidative stress markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in nerve function (m/s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of LVEF classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean time to halving of the maximal activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Symptom-free patients postoperatively
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intra-rater reliability of ENTAS 2 activity evaluations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-rater reliability of ENTAS 2 damage evaluations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-rater reliability of ENTAS 2 activity evaluations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients initiating home-based dialysis therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Deep surgical site infection (SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Difficulty in phonological awareness tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival free of acute rejection at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: Total and low density lipoprotein cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in ethanol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Closure time of the enterotomy (GJA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Need for extra stitches (GJA)
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative intraluminal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Adjusted BDNF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net anabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatty Acid (FA) of the gluteus medius muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Postoperative muscular atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Latency of middle latency responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Amplitude of middle latency responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Bishop score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: whole-body fat oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: postoperative levels of cTnI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: postoperative levels of CK-MB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: BUN improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: SCr improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: initial control of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sustained control of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: WSP-LPF scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: STARR scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of motorcycle drivers using reflective vests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with the screening process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bioequivalence of oseltamivir carboxylate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of MRM days per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with no MRM in any treated PMP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with naratriptan treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Iris color change
Endpoint domain: Adverse events/effects
Primary endpoint: Hb-CO concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical success at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacteriologic success at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of adverse experiences related to study treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Gait parameters (step and stride length, stance phase, swing phase, velocity, cadence)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognition scores at age 3 years
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Word reasoning scores at age 7 years
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Desensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tolerance maintenance after egg avoidance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Screw breakage
Endpoint domain: Adverse events/effects
Primary endpoint: Plate removal
Endpoint domain: Adverse events/effects
Primary endpoint: plasma malondialdehyde concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: tissue plasminogen activator (tPA) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: vascular cell-adhesion molecules (VCAM) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Malaria infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Increase in vocational activity participation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improvements in positive symptoms of psychosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in general symptoms of psychosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in bacterial colonies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Patient comprehension of preoperative rounds and postoperative complications
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Preoperative plasma adrenaline levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adrenaline levels after administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adrenaline-related side effects
Endpoint domain: Adverse events/effects
Primary endpoint: mean total societal cost per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: unilateral motor paralysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: unilateral sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: unilateral sympathetic block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Platelet aggregation at 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycoprotein IIb/IIIa expression at 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet/endothelial cell adhesion molecule-I expression at 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolongation period of pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: mean total score on the General Comfort Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean scores on the physical comfort subdimension
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean scores on the psychospiritual comfort subdimension
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean scores on the sociocultural comfort subdimension
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: change from baseline in trough FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average daily rate of canine retraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and persistent time of angina pectoris
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effective rates on UAP symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma levels of vWF, ET, sVCAM‐1, sICAM‐1, and NO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean pain decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FOSQ (Functional Outcomes of Sleep Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SNORE25
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ED50 for apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MENQOL total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Medical Outcomes Study-Sleep total score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Thirty-minute SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 1-h DBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cortisol salivary levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Nitrite concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total bacterial load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of deep periodontal pockets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of partners treated per original patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partner human immunodeficiency virus testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: hemodynamic demands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: M plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: M half-lives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: M peak concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak work load in maximal exercise testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DASH score improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of heel pressure ulcers (PUs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: eosinophils in nasal smear
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Retention of study knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: success rate of intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: insertion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: tachycardia during CPLA insertion
Endpoint domain: Adverse events/effects
Primary endpoint: Ankle-Brachial Index (ABI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: cavosurface marginal discoloration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pre-TEE distress and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: patient's discomfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: need for sedative administration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intraday blood glucose variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nocturnal hypoglycemia
Endpoint domain: Adverse events/effects